The overarching goal of the MMV Supply Grant is to increase access to malaria chemoprevention and severe malaria commodities. The outcome of the project is to improve increased availability and supply of quality assured malaria chemoprevention and severe malaria products.
more_horiz
Participating Organisations
Name
Type
Role
Medicines for Malaria Venture
Other Public Sector
Implementing
Transaction
Transaction Value
Provider
Receiver
Type
Date
82,859
USD
(Valued at Jul 13, 2023)
Unitaid
Medicines for Malaria Venture
Disbursement
date_range
Jul 13, 2023
1,001,096
USD
(Valued at Jul 29, 2021)
Unitaid
Medicines for Malaria Venture
Disbursement
date_range
Jul 29, 2021
974,516
USD
(Valued at Apr 30, 2019)
Unitaid
Medicines for Malaria Venture
Disbursement
date_range
Apr 30, 2019
1,279,691
USD
(Valued at Jul 17, 2018)
Unitaid
Malaria Medicines Venture (MMV)
Disbursement
date_range
Jul 17, 2018
630,222
USD
(Valued at Nov 17, 2017)
Unitaid
Malaria Medicine Venture
Disbursement
date_range
Nov 17, 2017
4,780,336
USD
(Valued at Oct 09, 2017)
Provider N/A
Receiver N/A
Commitment
date_range
Oct 09, 2017
Budget
4,780,336
USD
459,103
USD
(Valued at Oct 12, 2022)
date_range
Jan 01, 2017
-
Dec 31, 2017
705,882
USD
(Valued at Oct 12, 2022)
date_range
Jan 01, 2018
-
Dec 31, 2018
831,630
USD
(Valued at Jan 01, 2019)
date_range
Jan 01, 2019
-
Dec 31, 2019
580,950
USD
(Valued at Jan 01, 2020)
date_range
Jan 01, 2020
-
Dec 31, 2020
966,590
USD
(Valued at Oct 12, 2022)
date_range
Jan 01, 2021
-
Dec 31, 2021
1,030,667
USD
(Valued at Oct 12, 2022)
date_range
Jan 01, 2022
-
Dec 31, 2022
205,514
USD
(Valued at Oct 12, 2022)
date_range
Jan 01, 2023
-
Dec 31, 2023
access_time Updated on
Jul 21, 2023 13:53:04
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “I understand”, you consent to the use of ALL the cookies. Read more
